文献速递儿童内分泌与遗传代谢儿童消化与营养

1型糖尿病患儿乳糜泻特异性HLA基因分型筛查是否合理

Genotyping of coeliac-specific human leucocyte antigen in children with type 1 diabetes: does this screening method make sense?
PubMed 文献 · Arch Dis Child · 2016-12-30

作者认为ESPGHAN指南推荐将HLA基因分型作为1型糖尿病患儿一线筛查不合理,应定期进行乳糜泻特异性抗体筛查。

要点

  • 该队列中4例(3%)诊断为乳糜泻。
  • HLA基因分型作为1型糖尿病患儿一线筛查似乎不合理,应定期查乳糜泻抗体。

核心结论

  • 多数1型糖尿病患儿携带乳糜泻特异性HLA DQ2和/或DQ8基因型,HLA基因分型作为一线筛查不合理。
  • 1型糖尿病患儿需定期进行乳糜泻特异性抗体筛查。

研究设计与样本

  • 在因斯布鲁克和格拉茨医科大学医院招募的1型糖尿病患儿中进行HLA基因分型,采用PCR方法,统计用IBM-SPSS V.20。
  • 共纳入121例1型糖尿病患儿,男性52%,平均年龄13.3岁(SD 3.9),平均糖尿病诊断年龄7.4岁(SD 3.8),平均糖尿病病程5.9年(SD 3.3)。

主要发现

  • 仅8%无乳糜泻特异性HLA标记。
  • 4例(3%)患儿诊断为乳糜泻。

关键数值与推荐

  • ESPGHAN新筛查指南推荐对1型糖尿病等高危患者进行乳糜泻特异性HLA等位基因分型。

临床怎么用

  • 对于1型糖尿病患儿,不宜将乳糜泻特异性HLA基因分型作为一线筛查手段。
  • 应定期对1型糖尿病患儿进行乳糜泻特异性抗体筛查。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Due to a high linkage disequilibrium of diabetes and coeliac-specific human leucocyte antigen (HLA) genotypes, the prevalence of coeliac disease (CD) in children and adolescents with diabetes mellitus type 1 (T1D) is much higher than in the general population. Recently, the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) revised new screening guidelines in which genotyping for coeliac-specific HLA alleles is recommended for high-risk patients as patients with T1D. The aim of our study was to investigate the frequency and distribution of coeliac-specific HLA genotypes in paediatric patients with T1D. STUDY DESIGN: HLA genotyping was performed on paediatric patients with T1D, recruited at the Medical University Hospital of Innsbruck and Graz. The test was done by PCR. Statistical analysis was performed with IBM-SPSS V.20. RESULTS: In 121 paediatric patients with T1D (52% male), mean age 13.3 (SD 3.9) years, mean age at diabetes diagnosis 7.4 (SD 3.8) and mean diabetes duration of 5.9 (SD 3.3) years, HLA genotyping was conducted. Ninety-two per cent showed positive HLA DQ2 and/or HLA DQ8 genotypes. Thirty-four per cent carried HLA DQ2, 33% were HLA DQ2+DQ8 positive and 25% of the patients showed positive results for HLA DQ8 alone. Only 8% had no coeliac-specific HLA markers. Four (3%) patients were diagnosed with CD. CONCLUSIONS: The majority of paediatric patients with T1D has positive coeliac-specific HLA genotypes DQ2 and/or DQ8. Therefore, genotyping for coeliac-specific HLA alleles as a first-line test in patients with T1D as recommended in the ESPGHAN guidelines does not seem reasonable. Screening for coeliac-specific antibodies needs to be performed on a regular basis for patients with T1D.

来源:Arch Dis Child,查看原文。版权归原作者所有。

引用

  1. Binder E, Loinger M, Mühlbacher A, et al. Genotyping of coeliac-specific human leucocyte antigen in children with type 1 diabetes: does this screening method make sense? Arch Dis Child. 2016. PMID: 28039141. doi:10.1136/archdischild-2016-311610

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。